131I therapeutic efficacy of Graves disease and observed 498 cases.docVIP

 PAGE \* MERGEFORMAT 10 131I therapeutic efficacy of Graves disease and observed 498 cases [Abstract] Objective To study the 131I treatment of hyperthyroidism clinical disease. Methods 498 cases of Graves disease were retrospectively analyzed clinical data, the results of 1 498 patients with hyperthyroidism after 131I treatment of a low, normal thyroid function, hyperthyroidism partial response, invalid , respectively, 19.67%, 60.24%, 18.07%, 2.01%, 97.99% total efficiency, the recurrence rate was 0.8%. 6 months after treatment, the quality of the treatment of thyroid -20.39 reduced to 42.6 + 19.8 +-13.5g (t = 5.10, P lt;0.01,131 I treatment of hyperthyroidism eye total effective rate was 78%. Conclusion 131I treatment of Graves disease is safe and effective, as long as no contraindications who 131I therapy may be used as the preferred treatment, is superior to anti-thyroid drugs. [Keywords:] 131I effects of hyperthyroidism 131I has become the treatment of hyperthyroidism (referred to as one of the main methods of hyperthyroidism [1], the method is safe, convenient, economical, better efficacy, fewer side effects, recurrence rate, has been accepted by the majority of patients. Now 131I treatment 498 cases of hyperthyroidism patients were retrospectively reported: 1 Subjects and methods 1.1 Object June 2006 -2010 in May, in the course of Graves disease treated 498 cases were diagnosed by clinical and laboratory examinations, 154 patients were male, female 344 cases, aged 14-69 years, mean 36.2 years, course of 1 month -22.5 years, 132 cases of goiter grade (26.51%, degree in 310 cases (62.25%, degrees 56 cases (11.25%, 16 recurrence, 438 patients medical treatment with antithyroid drugs (ATD effects poor or relapse with the anti-time 3-36 months. 1.2 Treatment 1.2.1 patient preparation, patient, and iodine-containing food ATD disabled for at least 1 week, critically ill patients with -blockers ATP, coenzyme A, cytochrome c and ot